Regulatory science is a field of study that involves the application of scientific methods, principles, and data to the development and evaluation of regulatory policies, standards, and practices. In the context of real-world evidence (RWE), regulatory science plays an important role in evaluating the safety, efficacy (effectiveness), and quality of healthcare products and in developing evidence-based regulatory decisions.

Regulatory science in the context of RWE focuses on the use of RWE to support regulatory decision-making. This involves evaluating the quality and relevance of RWE for specific regulatory purposes, such as assessing the effectiveness of a new drug or medical device in a real-world setting. Regulatory science also involves developing and refining methodologies for generating and analyzing RWE, such as observational studies or real-world randomized controlled trials (e.g., pragmatic clinical trials, cluster randomized trials etc).

The use of RWE in regulatory decision-making is becoming increasingly important as stakeholders seek to better understand the real-world performance of healthcare products and as regulators seek to make more informed decisions based on the best available evidence. Regulatory science provides a framework for evaluating the quality and relevance of RWE and for ensuring that it is used appropriately in regulatory decision-making.

In summary, regulatory science in the context of RWE is a field of study that focuses on the use of scientific methods and data to support regulatory decision-making. It involves evaluating the quality and relevance of RWE, developing and refining methodologies for generating and analyzing RWE, and ensuring that RWE is used appropriately in regulatory decision-making.